Management of Chronic Immune Thrombocytopenia in Children and Adolescents: Lessons from an Austrian National Cross-Sectional Study of 81 Patients

Chronic immune thrombocytopenia (cITP) is often associated with an underlying predisposition towards autoimmunity, recognition of which is relevant to guide treatment. International recommendations on diagnostic steps and therapeutic measures of cITP in childhood exist. However, due to the low prevalence (1-2/100.000) and a variation of availability of immunological and hematological tests and treatments across pediatric units, we postulated that these guidelines are not uniformly adhered to and that immune dysregulation syndromes remained undiscovered.

Source: Seminars in Hematology - April 11, 2016 Category: Hematology Authors: J. Sipurzynski, B. Fahrner, R. Kerbl, R. Crazzolara, N. Jones, G. Ebetsberger, B. Jauk, V. Strenger, B. Wohlmuther, W. Schwinger, H. Lackner, C. Urban, W. Holter, M. Minkov, L. Kager, M. Benesch, M.G. Seidel Source Type: research